Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.
https://unsplash.com/photos/_jbClosDsD4
On June 22, 2021, PharmaTimes Online reported that the European Commission (EC) granted conditional approval to Koselugo (selumetinib), an orally administered therapy, for use in pediatric patients with neurofibromatosis…
Continue Reading
Koselugo Now EU Approved for NF1 and PN
During the European Hematology Association (EHA) Annual Congress (EHA2021), which took place virtually this year, hematological experts and stakeholders discussed new advances in the field. According to Fierce Biotech, one…
Continue Reading
EPZ-719 Shows Promise in Mice Models of MM
source: pixabay.com
In early June 2021, Epidermolysis Bullosa News reported that Filsuvez (Oleogel-S10), a topical gel for epidermolysis bullosa (EB), received Priority Review designation from the FDA. Filsuvez Developed by Amryt Pharma,…
Continue Reading
Filsuvez for EB Granted Priority Review
source: pixabay.com
In a news release from June 23, 2021, Revolo Biotherapeutics ("Revolo") shared that the FDA approved an Investigational New Drug (IND) application for the company's '1104 peptide treatment. Altogether, '1104…
Continue Reading
FDA Approves Revolo’s ‘1104 IND for EoE
Orphan Drug designation is a status granted to drugs or biologics intended to treat patients with rare conditions, defined as those affecting under 200,000 Americans. According to Pulmonary Hypertension News,…
Continue Reading
PT001 for PAH Earns Orphan Drug Status
source: pixabay.com
Mal de débarquement, or "sickness of disembarkment," is a phenomenon which causes a bobbing, rocking, or swaying sensation, alongside other symptoms. With many people, mal de débarquement only lasts…
Continue Reading
Raising MdDS Awareness: Brandy’s Story
source: pixabay.com
Alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV), or alveolar capillary dysplasia (ACD) for short, is a rare, congenital, and life-threatening disorder. Without receiving lung transplants in infancy,…
Continue Reading
Using High-Tech Nanoparticles to Treat ACD Pulmonary Issues
Transcription factor SOX 11 is encoded by the SOX11 gene. Altogether, this protein is known to play a role in embryonic neurogenesis and tissue formation. However, an estimated 90% of patients with…
Continue Reading
SOX 11 Inhibitors Could Treat MCL
[Source: pixabay.com]
When Taylor Brown was just two years old, her mother TaMetress Reed began noticing certain symptoms, such as hardening and tightening patches of skin. As Brown grew up, the symptoms…
Continue Reading
Taylor’s Journey Foundation Raises Scleroderma Awareness
https://unsplash.com/photos/P7MkoYvSnLI
According to a relatively recent news release from biopharmaceutical company Applied Therapeutics, Inc., AT-007 received Fast Track designation from the FDA. This therapy, which has also received both Orphan Drug…
Continue Reading
AT-007 for Galactosemia Granted Fast Track Designation
Internationally, over 400,000 people die of malaria each year. In many cases, a majority of these deaths occur in sub-Saharan Africa; children are the most vulnerable. However, according to Medical…
Continue Reading
Novel mRNA Vaccine Prevents Malaria in Mice Models
Unsplash: https://unsplash.com/photos/58Z17lnVS4U
For the first time, a research study has discovered a genetic marker related to high-risk neuroblastoma. According to Medical XPress, researchers determined that anaplastic lymphoma kinase (ALK) gene mutations and…
Continue Reading
Study Finds Genetic Marker for High-Risk Neuroblastoma
source: pixabay.com
As reported by Oncology Nursing News, gunagratinib (ICP-192) was recently granted Orphan Drug designation by the FDA. Altogether, this treatment is being evaluated as a potential treatment for patients…
Continue Reading
ICP-192 for Cholangiocarcinoma Granted Orphan Drug Status
source: pixabay.com
Currently, there are no real treatments for patients with primary mitochondrial myopathy (PMM). Most therapies, such as physical, occupational, or speech therapy, are designed to simply lessen or mitigate symptoms.…
Continue Reading
ICYMI: REN001 Receives Fast Track Designation for PMM
In late May 2021, the FDA granted accelerated approval to Truseltiq (infigratinib). As reported by Cure, this therapy is designed for adult patients with unresectable locally advanced, previously treated, or…
Continue Reading
Truseltiq Approved for Metastatic Cholangiocarcinoma
When Stephanie Ernst-Milner first discovered that she was having twins, she was speechless. But what she learned over the course of her pregnancy, and in the seven years since, has…
Continue Reading
Redefining TAPS: How Stephanie and the TAPS Support Foundation Raise Awareness
https://unsplash.com/photos/8rj4sz9YLCI
Mobility issues are common in patients with osteogenesis imperfecta (OI) - especially tendinopathy, or tendonitis. But why does this happen? According to Medical XPress, a study performed by Baylor College…
Continue Reading
Fkpb10 Deletion Causes Tendinopathy in Osteogenesis Imperfecta
source: pixabay.com
For years, researchers have been evaluating pridopidine, developed by Prilenia Therapeutics ("Prilenia"), as a potential therapy for patients with neurodegenerative conditions. As reported in HD Buzz, new research has highlighted…
Continue Reading
New Research Shows How Pridopidine Works in HD
Although it is still considered an experimental technique, gene therapy shows promise for treating a wide variety of genetic diseases or disorders. In a recent news release from the Sanford…
Continue Reading
AAV8-TNAP-D10 Could Be Effective HPP Treatment
Source: Pixabay
Over the past few years, Elmiron (pentosan polysulfate sodium, "PPS"), a therapy designed to treat patients with interstitial cystitis (IC), has been associated with potential vision damage. Despite a variety…
Continue Reading
Elmiron for IC Linked to Vision Loss
Photo by Robina Weermeijer on Unsplash
From June 5-8, 2021, the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) held its 58th Annual Virtual Meeting. Due to COVID-19, the meeting was held fully online. However, that…
Continue Reading
Dapagliflozin Benefits Patients with FSGS, Study Shows
Some conditions or diseases are more prevalent in certain groups. In the case of idiopathic intracranial hypertension (IIH), new research suggests that it is much more common in Black or…
Continue Reading
IIH Rates are Significantly Higher for Black and Hispanic Women
source: pixabay.com
Normally, cerebrospinal fluid (CSF) surrounds our brain and spinal cord, providing numerous benefits from injury protection and nutrient delivery to waste removal. Hydrocephalus, or "water on the brain," occurs when…
Continue Reading
CDI Startup Aims to Address Hydrocephalus
https://unsplash.com/photos/G6wVoIJY-iI
In a news release from late May 2021, biopharmaceutical company Timber Pharmaceuticals, Inc. ("Timber") shared that all patients have been enrolled in the Phase 2b CONTROL trial. During the trial,…
Continue Reading
All Patients Enrolled in TMB-001 Trial for Congenital Ichthyosis
Could a specialized cancer vaccine actually improve patient outcomes? According to a news release from biotechnology company AIVITA Biomedical, Inc. ("AIVITA"), the answer could be "yes." Citing data from a…
Continue Reading
AV-GBM-1 Improves Survival in Glioblastoma